Fujimoto Naohiro, Kubo Tatsuhiko, Hisaoka Masanori, Udo Kazuma, Yokomizo Akira, Shibuya Tadamasa, Wakeda Hironobu, Nishihara Kiyoaki, Moriya Ryosuke, Iwakuma Keiko
Department of Urology, University of Occupational and Environmental Health, Kitakyushu, Japan.
Department of Public Health, University of Occupational and Environmental Health, Kitakyushu, Japan.
Int J Urol. 2018 Jan;25(1):61-67. doi: 10.1111/iju.13469. Epub 2017 Oct 9.
To show the demographics, type of treatment and clinical outcomes of patients with retroperitoneal tumors in Japan.
We carried out a retrospective analysis of patients with retroperitoneal tumors treated between 2000 and 2012 at 12 university hospitals in Japan. Histology was re-evaluated using the 2013 World Health Organization classification.
A total of 167 patients were included in the analysis. The number of diagnosed patients increased over the 12-year study period. Liposarcoma and schwannoma were the most common histological types among intermediate/malignant and benign tumors, respectively. The intermediate/malignant tumors were larger and were more frequently found in older people. Surgical resection was the primary treatment for 151 patients. The median survival duration for patients with malignant tumors was 91 months, and was significantly shorter than that for patients with benign and intermediate tumors (P < 0.01). R2 resection was associated with significantly shorter survival than R0/R1 resection for malignant tumors (P < 0.01), but not for intermediate. Grossly complete resection of the recurrent tumors improved survival.
The number of patients diagnosed with retroperitoneal tumors increased over time. R2 resection of primary tumors was found to be associated with poor prognosis in malignant tumors, but not in intermediate tumors. Complete surgical resection of recurrent tumors was associated with a better oncological outcome.
展示日本腹膜后肿瘤患者的人口统计学特征、治疗类型及临床结局。
我们对2000年至2012年期间在日本12所大学医院接受治疗的腹膜后肿瘤患者进行了回顾性分析。组织学检查采用2013年世界卫生组织分类标准重新评估。
共有167例患者纳入分析。在12年的研究期间,确诊患者数量有所增加。脂肪肉瘤和神经鞘瘤分别是中间型/恶性肿瘤和良性肿瘤中最常见的组织学类型。中间型/恶性肿瘤体积更大,且在老年人中更常见。151例患者的主要治疗方式为手术切除。恶性肿瘤患者的中位生存时间为91个月,显著短于良性和中间型肿瘤患者(P < 0.01)。对于恶性肿瘤,R2切除的生存时间显著短于R0/R1切除(P < 0.01),但中间型肿瘤并非如此。复发性肿瘤的大体完全切除可改善生存。
随着时间推移,诊断为腹膜后肿瘤的患者数量增加。原发性肿瘤的R2切除在恶性肿瘤中与预后不良相关,但在中间型肿瘤中并非如此。复发性肿瘤的完全手术切除与更好的肿瘤学结局相关。